SCHEMBL21168173

SCHEMBL21168173

Cc1cccc2c3cncc(C)c3n(C)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALKBH5 Q6P6C2 1/20 0.55
FTO Q9C0B1 1/20 0.55
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
HCRTR1 O43613 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
CYP2A6 P11509 2/20 0.38
CYP1A2 P05177 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
GRM4 Q14833 5/20 0.35
ATP4A P20648 2/20 0.33
ATP4B P51164 2/20 0.33
ESR1 P03372 1/20 0.33
ATM Q13315 1/20 0.33
ALDH1A1 P00352 1/20 0.33
TOP2A P11388 1/20 0.33
CYP19A1 P11511 1/20 0.33
NQO2 P16083 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22808272 0.86 ALKBH5 (0.41) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL22808271 0.86 ALKBH5 (0.49) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL12382854 0.86 ALKBH5 (0.33) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL14931058 0.84 ALKBH5 (0.72) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL13100684 0.80 ALKBH5 (0.62) ALKBH5FTOKDM4EMAPTALDH1A1
SCHEMBL13564048 0.80 ALKBH5 (0.67) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL21803726 0.77 ALKBH5 (0.54) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL13100685 0.77 ALKBH5 (0.64) ALKBH5FTOMEN1NPC1HCRTR1
SCHEMBL22808276 0.76
SCHEMBL18253293 0.74 ALKBH5 (0.64) ALKBH5FTOMEN1NPC1HCRTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10873039-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-12-22 US disclosed
US-20190221749-A1 CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT KYULUX, INC. (JP) 2019-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10873039-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and diagnostic composition including the organometallic compound ORC3, LEF1, OCIAD1 ALKBH5 2199/4885FTO 200/4885MEN1 41/4885
US-20190221749-A1 CHARGE TRANSPORT MATERIAL, COMPOUND, DELAYED FLUORESCENT MATERIAL AND ORGANIC LIGHT EMITTING ELEMENT SLC43A1, SLC7A5, SLC39A3 ALKBH5 4113/4885FTO 1823/4885MEN1 1112/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.